1, Jerry Kelly, 88.89%. 2 (tie), Steven Alker, Alex Cejka and Steve Flesch, 87.04%. 5 (tie), Ernie Els, Mark Hensby, Thongchai Jaidee and Bernhard Langer, 85.19%. 9, Ken Tanigawa, 83.33%. 10, Brett ...

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated ...

Julian Harrison, an analyst from BTIG, reiterated the Buy rating on Cartesian Therapeutics (RNAC – Research Report). The associated price ...

In a report released today, Gil Blum from Needham maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report), with a price ...

The raised price target to $69 from $64 by Guggenheim reflects the firm's heightened confidence in Sphere Entertainment's ...

Cleveland's extreme cold weather this week resulted in some weather-related injuries, along with burst pipes and other fall ...

The field for 89th Masters on April 10-13 after the Latin American Amateur Championship, and now the players qualified for invitations ...

BMO Capital analyst Kostas Biliouris maintained a Buy rating on Korro Bio (KRRO – Research Report) yesterday and set a price target of ...

Leerink Partners analyst Thomas Smith has reiterated their bullish stance on RNAC stock, giving a Buy rating on January 13.Stay Ahead of the ...

Bernhard Langer won the Charles Schwab Cup Championship. Notes: The PGA Tour Champions begins its season on the Big Island in ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Korro Bio (KRRO – Research Report) today and set a price target of $180.00. The ...

Needham analyst Gil Blum maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report) today and set a price target of $41.00.Stay ...